CorMedix (CRMD) EBT Margin Growth (5y) (2018 - 2025)
CorMedix (CRMD) EBT Margin Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,930.72 Bn | 1,930.66 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 471.36 Bn | 466.57 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.47 Bn | 116.22 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.00 Bn | 62.00 Bn | - |
| 8 | Argenx Se | 56.08 Bn | 50.89 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | CorMedix | 5.07 Mn | -150.13 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 714,647.00 |
| Jun 30, 2025 | 5.45 Mn |
| Mar 31, 2025 | 782,285.00 |
| Dec 31, 2024 | -13.15 Mn |
| Sep 30, 2024 | 881,978.00 |
| Jun 30, 2024 | 1.46 Mn |
| Dec 31, 2022 | -1.66 Mn |
| Sep 30, 2022 | -8.75 Mn |
| Jun 30, 2022 | -3.34 Mn |
| Mar 31, 2022 | -8.60 Mn |
| Dec 31, 2021 | -3.57 Mn |
| Sep 30, 2021 | -197,047.00 |
| Jun 30, 2021 | -4.23 Mn |
| Mar 31, 2021 | -961,012.00 |
| Dec 31, 2020 | -12.27 Mn |
| Sep 30, 2020 | -5.62 Mn |
| Jun 30, 2020 | -5.45 Mn |
| Mar 31, 2020 | 996,546.00 |
| Dec 31, 2019 | 13.17 Mn |